Research in cancer transcriptomics. Writing on science, systems, and institutions.
San Diego · UCSD
Projects
Research Education · Ongoing
Co-founded the International Research Olympiad — the world's first olympiad-style competition dedicated solely to scientific research, building a global community of young researchers across 89+ countries.
Computational Biology · Completed
Analyzed survival associations across cancer transcriptomic datasets to compare single-gene and combinatorial gene-expression signatures across endpoints.
Healthcare Strategy · Completed
Developed Spill Prevention, Control, and Countermeasure (SPCC) compliance documentation and operational workflows for oil storage facilities under EPA regulatory requirements.
Writing
Featured
On noise, false positives, and the distance between significance and meaning
Notes on noise, false positives, survival endpoints, and the uncomfortable distance between statistical significance and biological meaning.
Essays
April 2, 2025
Taste, institutions, incentives, and why most projects fail early
A meditation on taste, institutions, incentives, and why most projects fail before they become technically difficult.
Notes
February 18, 2025
On explanation, optimism, fallibilism, and intellectual progress
A review of explanation, optimism, fallibilism, and what it means to make intellectual progress.
Book Reviews
January 8, 2025
About
San Diego · UC San Diego
I'm studying Molecular & Cell Biology and Business Economics at UC San Diego (expected 2028). My work sits where computation meets biology and where research meets decisions — cancer transcriptomics, biotech strategy, and the institutions that shape how young people learn to think scientifically.
I co-founded the International Research Olympiad, a global nonprofit building the world's first olympiad-style competition dedicated solely to scientific research — now reaching 13,000+ students across 89 countries, with finals hosted at Harvard.
On the technical side: TCGA survival and gene-combination analysis, codon optimization with transformers, variant annotation pipelines, and plant pathology research at the Indian Institute of Science. On the strategy side: precision oncology at Illudent Therapeutics, healthcare operations at Claisen, and work on diagnostics, clinical adoption, and translational decision-making.
I care about the gap between statistical significance and biological meaning — why biomarkers fail, what research education actually teaches, and how to build tools that make complex ideas legible without hiding the uncertainty.
Contact
Research, writing, collaborations, or serious conversations.